![Declining short interest is what makes S&P 500 vulnerable: JPMorgan](https://i-invdn-com.investing.com/news/LYNXNPEC660AC_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 8.180 | 8.180 | 0.000 |
Stocks | 91.820 | 91.820 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 30.077 | 21.786 |
Price to Book | 3.206 | 3.998 |
Price to Sales | 3.879 | 2.271 |
Price to Cash Flow | 18.940 | 16.838 |
Dividend Yield | 1.044 | 1.340 |
5 Years Earnings Growth | 11.467 | 11.393 |
Number of long holdings: 35
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Hoya Cor | JP3837800006 | 7.63 | 18,570.0 | +0.51% | |
Daiichi Sankyo | JP3475350009 | 6.73 | 5,450.0 | -0.26% | |
Chugai Pharmaceutical | JP3519400000 | 6.34 | 5,157.0 | +0.29% | |
Otsuka Holdings Ltd | JP3188220002 | 5.47 | 6,388.0 | +2.82% | |
Legend Bio | US52490G1022 | 5.37 | 42.61 | +4.44% | |
CSL | AU000000CSL8 | 5.21 | 293.00 | +0.78% | |
Celltrion | KR7068270008 | 4.63 | 177,100 | -1.67% | |
Takeda Pharmaceutical | JP3463000004 | 4.29 | 4,028.0 | +0.12% | |
Terumo Corp. | JP3546800008 | 3.94 | 2,579.0 | -0.52% | |
Samsung Biologics | KR7207940008 | 3.70 | 750,000 | +0.40% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bellevues Lux BB Adamant Medtech HB | 1.54B | 5.61 | -2.16 | 8.72 | ||
Adamant Medtech B EUR | 1.54B | 7.45 | 3.75 | 12.66 | ||
Adamant Medtech I EUR | 1.54B | 7.77 | 4.49 | 13.46 | ||
Adamant Medtech T EUR | 1.54B | 7.64 | 4.17 | 13.11 | ||
LU1477743386 | 390.55M | 3.71 | -1.55 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review